Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.10.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash Flows from Operating Activities    
Net loss $ (17,278) $ (27,129)
Adjustment to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 1,334 1,324
Amortization of intangible assets 3,804 4,094
Impairment of goodwill 8,392
Stock based compensation 979 1,282
Amortization of technology 50 50
Change in fair value of derivative liability (48) (254)
Amortization of debt discount 417 1,545
Amortization of deferred financing costs 167
Provision for doubtful accounts 221 773
Gain on the settlement of liabilities (307)
Gain on the sale of Sysorex Arabia (23)
Other (37) 129
Changes in operating assets and liabilities:    
Accounts receivable and other receivables 207 5,223
Inventory (19) 270
Other current assets 54 455
Prepaid licenses and maintenance contracts (5) 9,787
Other assets 34 46
Accounts payable (8,797) 4,751
Accrued liabilities (3,057) 455
Deferred revenue 64 (10,704)
Other liabilities (978) (438)
Total Adjustments (6,107) 27,347
Net Cash (Used in) Provided by Operating Activities (23,385) 218
Cash Flows Used in Investing Activities    
Purchase of property and equipment (39) (91)
Investment in capitalized software (661) (1,063)
Investment in technology (175)
Cash spun off a result of de-consolidation (362)
Net Cash Flows Used in Investing Activities (1,237) (1,154)
Cash Flows from Financing Activities    
Repayments to bank facility (1,141) (3,348)
Net proceeds from issuance of common stock, preferred stock and warrants 27,961 6,117
Repayment of notes payable (113) (20)
Advances to related party (774)
Repayments from related party 24
Repayment of debenture (2,850)
Net proceeds from convertible promissory notes 2,000
Repayment of convertible promissory notes (2,662)
Net Cash Provided by (Used In) Financing Activities 25,957 (763)
Effect of Foreign Exchange Rate on Changes on Cash (15) (15)
Net Increase (Decrease) in Cash and Cash Equivalents 1,320 (1,714)
Cash and Cash Equivalents - Beginning of period 119 1,821
Cash and Cash Equivalents - End of period 1,461 107
Cash paid for:    
Interest 798 545
Income Taxes
Supplemental disclosures of non-cash investing and financing activities:    
Common shares issued for extinguishment of debenture liability 1,456
Adjustment to opening retained earnings for the adoption of ASC 606 1,287
Deconsolidation of Sysorex net liabilities as a result of Spin-off $ 11,838